Antion Biosciences

Sven Kili, CEO 

Oct. 12 | 1:45pm | Oxford Biomedica Ballroom 

Geneva, Switzerland  

(Private) 

In-person Presentation 

Antion Biosciences is the world leader in efficient, safe and cost effective Cell Multiplexing technologies for almost any cell type. We develop cutting-edge allogeneic immuno- cell therapies in indications of high unmet medical and technical engineering need for patients who need hope to become reality. We will start by changing the way oncology cell therapies are developed. 

www.antion.ch 



By using this website you agree to accept our Privacy Policy and Terms & Conditions